As well as this study revealed that miRNA-155 could be used as a detection biomarker for HCC with a sensitivity of 88.8% and specificity of 91%and accuracy of 91.4% compared to AFP which had a sensitivity of 76.2% and specificity of 87.3% and accuracy of 81.0%)27. The gene discussed is AFP; the disease is hepatocellular carcinoma.